Economic evaluation of strategies for the control and management of influenza in Europe (Q57574479)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057614%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Economic evaluation of strategies for the control and management of influenza in Europe (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057614%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057614%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

P A West

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057614%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

English

0 references

publication date

1 June 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057614%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057614%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057614%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

19-20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057614%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

2562-2578

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057614%20AND%20SRC:MED&resulttype=core&format=json

Individual and community impact of influenza

9 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Health impact of influenza in the United States.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Prevention and early treatment of influenza in healthy adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

French economic evaluations of influenza and influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Cost-effectiveness of the influenza vaccine in a healthy, working-age population.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Influenza vaccination programs for elderly persons: cost-effectiveness in a health maintenance organization

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Prevention and control of type A influenza infections in nursing homes. Benefits and costs of four approaches using vaccination and amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Economic evaluation of vaccination against influenza in New Zealand.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Benefits of influenza vaccination for low-, intermediate-, and high-risk senior citizens

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Excess hospital admissions for pneumonia and influenza in persons [gt-or-equal, slanted]65 years associated with influenza epidemics in three English health districts: 1987–95

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Influenza burden of illness: estimates from a national prospective survey of household contacts in France.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Sequential outbreak of influenza A and B in a nursing home: efficacy of vaccine and amantadine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Adherence to a prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Medication compliance as a feature in drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Noncompliance may render migraine prophylaxis useless, but once-daily regimens are better

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

Socioeconomic evaluation in medicine in Europe. Core economic concepts.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900154-8

7 January 2021

10.1016/S0264-410X(02)00154-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12057614%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference